Tuberculosis drug discovery in the CRISPR era

Open Access

Pearls provide concise, practical and educational insights into topics that span the pathogens field.

About the Authors

Jeremy Rock

* E-mail: rock@rockefeller.edu

Affiliation Laboratory of Host-Pathogen Biology, The Rockefeller University, New York, New York, United States of America

The author has declared that no competing interests exist.

Tuberculosis drug discovery
Is the Subject Area "Tuberculosis drug discovery" applicable to this article?

Thanks for your feedback.
Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
Antibiotics
Is the Subject Area "Antibiotics" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Extensively drug-resistant tuberculosis
Is the Subject Area "Extensively drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.